I work closely with the CoMH Vice Dean for Research and Innovation, Dr Michael Clarkson, to support clinicians and other healthcare staff affiliated with UCC who wish to be research active. I also support the CoMH Research Committee and the CoMH Graduate Studies Committee to help advance research within the CoMH, and promote academic-clinical collaborations.
I am a member of the UCC Horizon Europe Task Force, the IUA (Irish Universities Association) Research Officers Group, of EARMA (the European Association of Research Managers and Administrators) and of the BESTPRAC Cost Action Network.
Biography
Following over 7 years as a researcher in the area of biochemistry and cell signalling, I took up the role of RMA (Research Manager/Administrator) in the College of Medicine and Health. I provide expertise and support to researchers in areas such as identifying a grant that is appropriate for your interests and career stage, identifying future grants and building up the required track record, proposal development, proposal review, finding collaborators and building a consortium.I work closely with the CoMH Vice Dean for Research and Innovation, Dr Michael Clarkson, to support clinicians and other healthcare staff affiliated with UCC who wish to be research active. I also support the CoMH Research Committee and the CoMH Graduate Studies Committee to help advance research within the CoMH, and promote academic-clinical collaborations.
I am a member of the UCC Horizon Europe Task Force, the IUA (Irish Universities Association) Research Officers Group, of EARMA (the European Association of Research Managers and Administrators) and of the BESTPRAC Cost Action Network.
Research Interests
Research Development with a particular interest in the European Framework Programmes, currently Horizon Europe. Publications
Peer Reviewed Journals
| Year | Publication | |
|---|---|---|
| (2016) | 'The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa' Byrne, A. M.,Roche, S. L.,Ruiz-Lopez, A. M.,Jackson, A. C. W.,Cotter, T. G. (2016) 'The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa'. Molecular Vision, 22 :264-274 [Details] | |
| (2016) | 'The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration' Byrne, A. M.,Ruiz-Lopez, A. M.,Roche, S. L.,Moloney, J. N.,Wyse -Jackson, A. C.,Cotter, T. G. (2016) 'The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration'. Redox Biology, 10 :128-139 [DOI] [Details] | |
| (2015) | 'The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus' Byrne, A. M.,Elliott, C.,Hoffmann, R.,Baillie, G. S. (2015) 'The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus'. FEBS Letters, 589 (6):750-755 [DOI] [Details] | |
| (2014) | 'The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells' Henderson, D. J. P.,Byrne, A.,Dulla, K.,Jenster, G.,Hoffmann, R.,Baillie, G. S.,Houslay, M. D. (2014) 'The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells'. British Journal of Cancer, 110 (5):1278-1287 [DOI] [Details] |
Professional Activities
Professional Associations
| Association | Function | From / To | |
|---|---|---|---|
| BestPrac COST Targeted Network for Research Administrators | member | / | |
| Irish Universities Research Officers Group | member | / | |
| UCC H2020 Task Force | member | / |